MultiCell Technologies, Inc. (OTCBB:MCET), developer of therapeutics for the treatment of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases, today announced that Company President Dr. Stephen Chang will present an overview of MultiCell’s drug development pipeline and partnership opportunities at the BIO 2006 biotechnology conference.
